Big Gain For Aravive, Inc.

Tue, Oct 17, 2023 at 07:17 PM

Aravive, Inc. (ARAV:NASDAQ) soared at $0.22, representing a gain of 61.9%. On Tue, Oct 17, 2023, ARAV:NASDAQ hit a New 2-Week High of $0.22. From Tue, Oct 03, 2023, the stock recorded 30.00% Up Days and 45.45% Green Days

About Aravive, Inc. (ARAV:NASDAQ)

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Top 10 Gainers:

SciSparc Ltd. (SPRC:NASDAQ), 122.97%
Nkarta Inc. (NKTX:NASDAQ), 112.16%
Viveve Medical, Inc. (VIVE:NASDAQ), 78.95%
Assembly Biosciences, Inc. (ASMB:NASDAQ), 72.18%
Olink Holding AB (publ) (OLK:NASDAQ), 66.02%
Aravive, Inc. (ARAV:NASDAQ), 61.9%
Anebulo Pharmaceuticals Inc. (ANEB:NASDAQ), 42.69%
RedHill Biopharma Ltd. (RDHL:NASDAQ), 34.1%
Gamer Pakistan Inc. (GPAK:NASDAQ), 32%
Ramaco Resources, Inc. (METC:NASDAQ), 28.82%